Trendlines Group Ltd. · SGX:42T
Trendlines — The Trendlines Group — Q3 2018 Earnings Presentation
16 slides from Trendlines's earnings presentation, Nov 8, 2018
Slide 1: The Trendlines Group Financial Highlights Q3 2018
The Trendlines Group Financial Highlights Q3 2018 Steve Rhodes Todd Dollinger Haim Brosh Chairman and CEO Chairman and CEO Chief Financial Officer 8 November 2018 SGX:42T OTCQX: TRNLY
Slide 2: Agenda
Agenda • Corporate highlights • Financial highlights • Post Q3 2018 developments 2
Slide 3: Legal disclaimer
Legal disclaimer Important notice This presentation is for informational purposes only and does not constitute or form any part of any offer for sale or subscription of, or solicitation of, any offer to buy or subscribe for any securities of The Trendlines Group Ltd. (“Company”) or any of its portfo
Slide 4: Corporate highlights
Corporate highlights
Slide 5: 11 years of portfolio value expansion
11 years of portfolio value expansion US$ millions Portfolio value with exit proceeds 140 120 Portfolio value* 100 Cumulative exit proceeds 80 60 40 20 0 30.12.08 30.12.09 30.12.10 30.12.11 31.12.12 31.12.13 31.12.14 31.12.15 31.12.16 31.12.17 30.09.18 *Portfolio value includes the fair value of inv
Slide 6: Key financial developments Q3
Key financial developments Q3 Q3 2018 31 December 2017 Change % Change Portfolio value US$ 102.5 million US$ 96.8 million US$ 5.7 million 5.9% Book value US$ 92.8 million US$ 92.9 million - US$ 0.1 million not material Current assets US$ 13.9 million US$ 20.4 million - US$ 6.5 million -31.9% Q3 2018
Slide 7: Q3 2018 developments
Q3 2018 developments • B. Braun Medical SAS, acquirer of Stimatix GI Ltd.’s assets, confirmed product launch remains on schedule for worldwide rollout. • Hyblate Medical Ltd. - new medical portfolio company established in Israel. • The SIAS 19th INVESTORS' CHOICE AWARDS named Trendlines “Winner of S
Slide 8: 10 companies to watch
10 companies to watch* • ApiFix Ltd. • Leviticus Cardio Ltd. • Arcuro Medical Ltd. • OrthoSpin Ltd. • BioFishency Ltd. • Saturas Ltd. • Fidmi Medical Ltd. • STS Medical Ltd. • ViAqua Therapeutics Ltd. • Gordian Surgical Ltd. *Updated report issued: 24 October 2018 8
Slide 9: Q3 highlights from the "10 Companies to Watch" report
Q3 highlights from the “10 Companies to Watch” report • ApiFix Ltd. and Gordian Surgical Ltd. completed >250 surgeries and >500 surgeries respectively • Arcuro Medical Ltd. completed 4 successful first-in-human meniscus repair procedures • STS Medical Ltd. successfully implanted and removed sinus st
Slide 10: Financial highlights
Financial highlights
Slide 11: Consolidated income statement
Consolidated income statement Group Three Months Ended 30 September 2018 30 September 2017 (Unaudited) (Unaudited) Change US$’000 US$’000 % Income: Gain from change in fair value of investments in Portfolio Companies 4,527 5,252 (13.80) Income from services to Portfolio Companies 1,323 1,265 4.58 Gr
Slide 12: Key value components
Key value components Change in portfolio value during 9M 2018 Balance sheet as at 30 September 2018 (US$ millions) 13.9 (3.5) (4.1) (15.1) 11.4 (5.7) (0.9) 96.8 102.5 92.8 Net portfolio Investments Fair value Net portfolio Cash, short- Fair value of Deferred Deferred tax** Payables & Total equity va
Slide 13: Post Q3 2018 developments
Post Q3 2018 developments
Slide 14: Post Q3 2018 developments
Post Q3 2018 developments • FruitSpec Ltd. announced the completion of successful field studies and received patent in the United States for its fruit yield estimate technology. • liberDi Ltd. completed successful pre-clinical trials for their portable, home dialysis system. • Escala Ltd. launched a
Slide 15: Meet us 26 - 29 November in Singapore
Meet us 26 - 29 November in Singapore Look Ahead to Agtech! o Corporate updates from Steve Rhodes o Agtech news from Nitza Kardish o Meet three agtech company CEOs Agri-Food Innovation Week (27-29 November) o Nitza Kardish is a speaker o Steve Rhodes is a judge o Three Trendlines agtech companies wi
Slide 16: SGX: 42T OTCQX: TRNLY www.trendlines.com
SGX: 42T Steve Rhodes, Chairman & CEO OTCQX: TRNLY steve@trendlines.com Todd Dollinger, Chairman & CEO +972.72.260.7000 todd@trendlines.com www.trendlines.com Haim Brosh, Chief Financial Officer haim@trendlines.com 8 November 2018